Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

More and more scientists are taking advantage of DNA microarray chip technology to further their research. PubMed can give a rough estimate of the growth and acceptance of this technology; a search ...

Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

This year’s most innovative smaller companies prove that head count doesn’t cap ambition. These Small and Mighty standouts (51 to 200 employees) are thinking well beyond their ...

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

The whole-exome sequencing (WES) significantly improves diagnostic accuracy for monogenic foetal structural anomalies (FSAs), ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for ...

Abnormal expression of microRNAs (miRNAs) in cancer suggests their applicability as diagnostic and prognostic signatures. Here we describe a new microarray platform, miRCURY™ LNA, based on Locked ...

A cheap home DNA kit seemed like a bit of fun – until the results exposed hidden ancestry and a family secret no one had prepared for.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Hi and welcome to our monthly video series called what’s trending online. At the HCP site there are six articles that readers ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, enabling timely medical guidance and informed decision-making.